Allarity Therapeutics, Inc.
ALLR • NASDAQ
Allarity Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas H. Jensen, with a market cap of $13.0M.
CEOThomas H. Jensen
Market Cap$13.0M
Biotechnology
Healthcare
Employees6.0
Websiteallarity.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Allarity Therapeutics, Inc.
Date
Monday, March 30, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.22
Earnings History
Past 12 earnings reports for Allarity Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.19Est: -$0.23 | +17.4% | - | — |  10-Q |
| Aug 15, 2025 | Q2 2025 | -$0.15Est: -$0.21 | +28.6% | - | — | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.25 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$1.72Est: -$8.10 | +78.8% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$7.71Est: -$8.40 | +8.2% | - | — | 10-Q |
| Aug 5, 2024 | Q2 2024 | -$0.11Est: -$0.29 | +62.1% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$22.14 | — | - | — | 10-Q |
| Mar 8, 2024 | Q4 2023 | -$6.80Est: -$5.00 | -36.0% | - | — | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$44.80Est: -$163.40 | +72.6% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$525.60Est: -$223.80 | -134.9% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$3,544.00Est: -$6,304.00 | +43.8% | - | — | — |
| Mar 13, 2023 | Q4 2022 | -$6,440.00Est: -$11,760.00 | +45.2% | - | — | — |